High expression levels of CUL4A were associated with better PFS for trabectedin in nontranslocation-related sarcomas [16]; however, protein expression analysis showed an unexpected association between worse PFS and cases with high expression of CUL4A in our series. The gene discussed is CUL4A; the disease is sarcoma.